Cargando…

Monitoring surfactants and their role in the SARS-COV-2 Vaccine

Detalles Bibliográficos
Autor principal:	Gabriel-Caldwell, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825858/ http://dx.doi.org/10.1016/j.fos.2021.01.001

Ejemplares similares

Cationic Surfactants as Disinfectants against SARS-CoV-2
por: Karamov, Eduard V., et al.
Publicado: (2022)

In-line monitoring of surfactant clearance in viral vaccine downstream processing
por: Payne, Jessie, et al.
Publicado: (2021)

Surfactants – Compounds for inactivation of SARS-CoV-2 and other enveloped viruses
por: Simon, Miriam, et al.
Publicado: (2021)

Adsorption of Pulmonary and Exogeneous Surfactants on SARS-CoV-2 Spike Protein
por: Santo, Kolattukudy P., et al.
Publicado: (2023)

Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination
por: Guiomar, Raquel, et al.
Publicado: (2022)

Pulmonary surfactant itself must be a strong defender against SARS-CoV-2
por: Takano, Hideyuki
Publicado: (2020)

Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity
por: Du, Kang, et al.
Publicado: (2022)

Antiseptic Polymer–Surfactant Complexes with Long-Lasting Activity against SARS-CoV-2
por: Molchanov, Vyacheslav S., et al.
Publicado: (2022)

Tailored lipopeptide surfactants as potentially effective drugs to treat SARS-CoV-2 infection
por: Biria, Davoud
Publicado: (2022)

Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection
por: Salvioni, Lucia, et al.
Publicado: (2022)

Effect of Vaccination on Transmission of SARS-CoV-2
por: Shah, Anoop S.V., et al.
Publicado: (2021)

Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2
por: Routledge, Isobel, et al.
Publicado: (2021)

Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2
por: Routledge, Isobel, et al.
Publicado: (2022)

Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury
por: Cattel, Francesco, et al.
Publicado: (2021)

Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia?
por: Laganà, Antonio Simone, et al.
Publicado: (2020)

Silver nanoparticles with excellent biocompatibility block pseudotyped SARS-CoV-2 in the presence of lung surfactant
por: Gupta, Govind, et al.
Publicado: (2022)

Lung Surfactant Levels are Regulated by Ig-Hepta/GPR116 by Monitoring Surfactant Protein D
por: Fukuzawa, Taku, et al.
Publicado: (2013)

Post-SARS-CoV-2 Vaccine Monitoring of Disease Flares in Autoinflammatory Diseases
por: Alehashemi, Sara, et al.
Publicado: (2022)

LYMPHOHISTIOCYTIC MYOCARDITIS FOLLOWING SARS-COV-2 VACCINE
por: Sharma, Arushi, et al.
Publicado: (2022)

Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020)

Monitoring and immunogenicity of SARS-CoV-2 vaccination of laboratory rhesus monkeys (Macaca mulatta)
por: Oh, Dan Qi Priscilla, et al.
Publicado: (2023)

The role of surfactant in asthma
por: Hohlfeld, Jens M
Publicado: (2002)

Predictors of Serological Response to SARS-CoV-2 Vaccination in Kidney Transplant Patients: Baseline Characteristics, Immunosuppression, and the Role of IMPDH Monitoring
por: Liefeldt, Lutz, et al.
Publicado: (2022)

Salt and surfactant coated filters with antiviral properties and low pressure drop for prospective SARS-CoV2 applications
por: Ebadi, Milad, et al.
Publicado: (2022)

Role of COVID-19 Vaccines in SARS-CoV-2 Variants
por: Zhou, Zhou, et al.
Publicado: (2022)

Single-dose SARS-CoV-2 vaccination efficacy in the elderly
por: Prendecki, Maria, et al.
Publicado: (2021)

SARS-CoV-2 vaccine strategies in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2023)

Saliva-Based ELISAs for Effective SARS-CoV-2 Antibody Monitoring in Vaccinated Individuals
por: Casian, Joseph G., et al.
Publicado: (2021)

Sars-Cov-2 Antibody Decay Monitoring in mRNA Vaccinated Multiple Myeloma Patients
por: Stampfer, Samuel D., et al.
Publicado: (2021)

Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2
por: Monzon-Posadas, Werner O., et al.
Publicado: (2023)

Monitoring Serum Spike Protein with Disposable Photonic Biosensors Following SARS-CoV-2 Vaccination
por: Cognetti, John S., et al.
Publicado: (2021)

Simplifying glycan monitoring of complex antigens such as the SARS-CoV-2 spike to accelerate vaccine development
por: Sauvageau, Janelle, et al.
Publicado: (2023)

Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice
por: Sundaram, Appavu K., et al.
Publicado: (2021)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Vaccines against SARS-COV-2
por: Kim, Jerome H.
Publicado: (2021)

Monitoring and tracking the spread of SARS-CoV-2 in Asturias, Spain
por: Gonzalez-Alba, Jose Maria, et al.
Publicado: (2023)

Synergistic effects of anionic surfactants on coronavirus (SARS-CoV-2) virucidal efficiency of sanitizing fluids to fight COVID-19
por: Jahromi, Reza, et al.
Publicado: (2020)

Nanocarrier vaccines for SARS-CoV-2
por: Machhi, Jatin, et al.
Publicado: (2021)

SARS-CoV-2 vaccine development
por: Mtewa, Andrew G., et al.
Publicado: (2022)

Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control
por: Delgado, Rafael
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p84g9cugqinha1cmrbk272lu7v